Barbloc 5 tablet Australia - English - Department of Health (Therapeutic Goods Administration)

barbloc 5 tablet

alphapharm pty ltd - pindolol, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica - indications as at 18 november 2004: hypertension (either alone or in combination with other antihypertensive drugs). angina pectoris (prevention of attacks). cardiac arrhythmias [sinus tachycardia, paroxysmal tachycardia, supraventricular and ventricular extrasystoles, drug induced extrasystoles (digitalis), atrial flutter and fibrillation - to slow the ventricular rate]. functional hyperadrenergic cardiac disturbances (hyperkinetic heart syndrome, neurocirculatory asthenia).

PILOCARPINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet, film coated

actavis pharma, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

PILOCARPINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet, film coated

marlex pharmaceuticals inc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets, usp are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren’s syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

PILOCARPINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet, film coated

lannett company, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets, usp are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

PILOCARPINE HYDROCHLORIDE TABLETS, USP Canada - English - Health Canada

pilocarpine hydrochloride tablets, usp

sterimax inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

M-PILOCARPINE TABLET Canada - English - Health Canada

m-pilocarpine tablet

mantra pharma inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

PILOCARPINE HYDROCHLORIDE TABLETS Canada - English - Health Canada

pilocarpine hydrochloride tablets

methapharm inc - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

PILOCARPINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet, film coated

physicians total care, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

PILOCARPINE HYDROCHLORIDE tablet United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet

rebel distributors corp - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hcl tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome. pilocarpine hcl tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

PILOCARPINE HYDROCHLORIDE tablet, film coated United States - English - NLM (National Library of Medicine)

pilocarpine hydrochloride tablet, film coated

amneal pharmaceuticals of new york llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren’s syndrome. pilocarpine hydrochloride tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.